VYNE Therapeutics Inc
VYNE Therapeutics Inc (VYNE) is known on NASDAQ - United States, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerVYNE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodQ1 2026
- RevenueUSD 86.00K
- Net income-USD 3.59M
- Free cash flow-USD 25.74M